Abstract:In biopharmaceutical manufacturing, fermentation processes play a critical role in productivity and profit. A fermentation process uses living cells with complex biological mechanisms, leading to high variability in the process outputs, namely, the protein and impurity levels. By building on the biological mechanisms of protein and impurity growth, we introduce a stochastic model to characterize the accumulation of the protein and impurity levels in the fermentation process. However, a common challenge in the industry is the availability of only a very limited amount of data, especially in the development and early stages of production. This adds an additional layer of uncertainty, referred to as model risk, due to the difficulty of estimating the model parameters with limited data. In this paper, we study the harvesting decision for a fermentation process (i.e., when to stop the fermentation and collect the production reward) under model risk. We adopt a Bayesian approach to update the unknown parameters of the growth-rate distributions, and use the resulting posterior distributions to characterize the impact of model risk on fermentation output variability. The harvesting problem is formulated as a Markov decision process model with knowledge states that summarize the posterior distributions and hence incorporate the model risk in decision-making. Our case studies at MSD Animal Health demonstrate that the proposed model and solution approach improve the harvesting decisions in real life by achieving substantially higher average output from a fermentation batch along with lower batch-to-batch variability.

Stochastic Simulation Model Development For Biopharmaceutical Production Process Risk Analysis And Stability Control

Stochastic Simulation Uncertainty Analysis to Accelerate Flexible Biomanufacturing Process Development

Biomanufacturing Harvest Optimization with Small Data

Interpretable Biomanufacturing Process Risk and Sensitivity Analyses for Quality-by-Design and Stability Control

KT-Biologics I (KTB1): A Dynamic Simulation Model for Continuous Biologics Manufacturing

Use of Monte Carlo simulations for improved facility fit planning in downstream biomanufacturing and technology transfer

Modeling nonlinear stochastic kinetic system and stochastic optimal control of microbial bioconversion process in batch culture

Stability Modeling Methodologies to Enable Earlier Patient Access

A Stochastic Model of Microbial Bioconversion Process in Batch Culture

Stochastic Process Optimization of an Integrated Biorefinery

An examination of process models and model risk frameworks for pharmaceutical manufacturing

Modeling Production Scheduling Considering Stability

Biopharmaceutical Process Optimization with Simulation and Scheduling Tools.

A multi-stage stochastic programming model for adaptive biomass processing operation under uncertainty

Review of Advanced Physical and Data-Driven Models for Dynamic Bioprocess Simulation: Case Study of Algae-Bacteria Consortium Wastewater Treatment.

Stochastic Simulation of Biomolecular Networks in Dynamic Environments

Stochastic Molecular Reaction Queueing Network Modeling for In Vitro Transcription Process

Designing Robust Biotechnological Processes Regarding Variabilities using Multi-Objective Optimization Applied to a Biopharmaceutical Seed Train Design

De-risking pharmaceutical tablet manufacture through process understanding, latent variable modeling, and optimization technologies

Practical algorithm for stochastic optimal control problem about microbial fermentation in batch culture

Stochastic biological system-of-systems modelling for iPSC culture